Christina Therkildsen

Learn More
BACKGROUND In metastatic colorectal cancer, mutation testing for KRAS exon 2 is widely implemented to select patients with wild-type tumors for treatment with the monocloncal anti-EGFR antibodies(More)
DOI: 10.1111/iju.13094 Lynch syndrome is a multi-tumor syndrome caused by mutations in the MMR genes MLH1, MSH2, MSH6 and PMS2. Mutation carriers are at increased risk of a number of tumor types; for(More)